ZFIN ID: ZDB-FISH-200810-5
Fish name: gper1zf2223/zf2223
Genotype: gper1zf2223/zf2223
Targeting Reagent: none
HUMAN DISEASE MODELED by gper1zf2223/zf2223
No data available
GENE EXPRESSION
Gene expression in gper1zf2223/zf2223
Reporter gene expression No data available
PHENOTYPE
Phenotype in gper1zf2223/zf2223
Phenotype Conditions Figures
female organism liver increased mass, abnormal chemical treatment by environment: 17beta-estradiol Fig. 6 from Chaturantabut et al., 2019
female organism liver increased weight, abnormal chemical treatment by environment: 17beta-estradiol Fig. 6 from Chaturantabut et al., 2019
liver decreased size, abnormal control Fig. 4 from Chaturantabut et al., 2019
liver decreased size, abnormal chemical treatment by environment: MK-2206 Fig. 4 from Chaturantabut et al., 2019
liver decreased size, abnormal chemical treatment by environment: MK-2206, chemical treatment by environment: 17beta-estradiol Fig. 4 from Chaturantabut et al., 2019
liver decreased size, abnormal chemical treatment by environment: G-1 Fig. 4 from Chaturantabut et al., 2019
liver decreased size, abnormal chemical treatment by environment: 17beta-estradiol Fig. 4 from Chaturantabut et al., 2019
liver neoplastic, ameliorated chemical treatment by environment: 7,12-dimethyltetraphene Fig. 7 from Chaturantabut et al., 2019
liver size, ameliorated chemical treatment by environment: effector Fig. 4 from Chaturantabut et al., 2019
male organism liver ab5-akt labeling amount, ameliorated chemical treatment by environment: 17beta-estradiol Fig. 6 from Chaturantabut et al., 2019
male organism liver increased mass, ameliorated chemical treatment by environment: 17beta-estradiol Fig. 6 from Chaturantabut et al., 2019
male organism liver increased weight, ameliorated chemical treatment by environment: 17beta-estradiol Fig. 6 from Chaturantabut et al., 2019
whole organism gper1 expression absent, abnormal standard conditions Fig. S3 from Chaturantabut et al., 2019
whole organism ab1-rps6 labeling amount, ameliorated chemical treatment by environment: 17beta-estradiol Fig. 4 from Chaturantabut et al., 2019
whole organism ab1-rps6 labeling amount, ameliorated chemical treatment by environment: G-1 Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling amount, ameliorated chemical treatment by environment: effector Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling decreased amount, abnormal control Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling decreased amount, abnormal chemical treatment by environment: MK-2206, chemical treatment by environment: 17beta-estradiol Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling decreased amount, abnormal chemical treatment by environment: MK-2206 Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling decreased amount, abnormal chemical treatment by environment: 17beta-estradiol Fig. 4 from Chaturantabut et al., 2019
whole organism ab5-akt labeling increased amount, abnormal chemical treatment by environment: G-1 Fig. 4 from Chaturantabut et al., 2019

CITATIONS  (1)